Yoshiro Sohma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoshiro Sohma has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Tzyh-Chang Hwang
John M. Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, Missouri 65211, USA
3 shared publicationsYing-Chun Yu
Departments of Pharmacology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan
3 shared publicationsHiroyasu Shimizu
John M. Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211, USA
2 shared publicationsMasato Yasui
Department of Pharmacology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan
2 shared publications- Tzyh-Chang Hwang
National yang Ming Chiao Tung University
2 shared publications Akiko Hanyuda
Department of Pharmacology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan
1 shared publication
Latest Publications
- 1 April 2013
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 19 (19) , 3521-3528
Curcumin and Genistein: the Combined Effects on Disease-associated CFTR Mutants and their Clinical Implications
Genistein and curcumin are major components of Asian foods, soybean and curry turmeric respectively. These compounds have been intensively investigated for their chemical and biological features conferring their anti-cancer activity. Genistein and curcumin have also been investigated for their potentiation effects on disease-associated CFTR mutants such as ΔF508 and G551D. Recently, we investigated the combined effect of genistein and curcumin on G551D-CFTR, which exhibits gating defects without abnormalities in protein synthesis or trafficking using the patch-clamp technique. We found that genistein and curcumin showed additive effects on their potentiation of G551D-CFTR in high concentration range and also, more importantly, showed a significant synergistic effect in their minimum concentration ranges. These results are consistent with the idea that multiple mechanisms are involved in the action of these CFTR potentiators. In this review, we revisit the pharmacology of genistein and curcumin on CFTR and also propose new pharmaceutical implications of combined use of these compounds in the development of drugs for CF pharmacotherapy.
- 1 April 2013
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 19 (19) , 3521-3528
Curcumin and Genistein: the Combined Effects on Disease-associated CFTR Mutants and their Clinical Implications
Genistein and curcumin are major components of Asian foods, soybean and curry turmeric respectively. These compounds have been intensively investigated for their chemical and biological features conferring their anti-cancer activity. Genistein and curcumin have also been investigated for their potentiation effects on disease-associated CFTR mutants such as ΔF508 and G551D. Recently, we investigated the combined effect of genistein and curcumin on G551D-CFTR, which exhibits gating defects without abnormalities in protein synthesis or trafficking using the patch-clamp technique. We found that genistein and curcumin showed additive effects on their potentiation of G551D-CFTR in high concentration range and also, more importantly, showed a significant synergistic effect in their minimum concentration ranges. These results are consistent with the idea that multiple mechanisms are involved in the action of these CFTR potentiators. In this review, we revisit the pharmacology of genistein and curcumin on CFTR and also propose new pharmaceutical implications of combined use of these compounds in the development of drugs for CF pharmacotherapy.
- 1 July 2011
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 10 (4) , 243-252
Curcumin and genistein additively potentiate G551D-CFTR
- 1 July 2011
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 10 (4) , 243-252
Curcumin and genistein additively potentiate G551D-CFTR
- Open Access
- 14 July 2010
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 60 (5) , 353-362
A stable ATP binding to the nucleotide binding domain is important for reliable gating cycle in an ABC transporter CFTR
- 14 July 2010
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 60 (5) , 353-362
Open AccessA stable ATP binding to the nucleotide binding domain is important for reliable gating cycle in an ABC transporter CFTR
- 1 January 2010
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 50 (5) , 228-231
Mechanism of "NBD engine" in an ABC transporter, CFTR channel
- 1 January 2010
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 50 (5) , 228-231
Mechanism of "NBD engine" in an ABC transporter, CFTR channel
- Open Access
- 1 October 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (44) , 30300-30310
Three-dimensional Reconstruction of Human Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Revealed an Ellipsoidal Structure with Orifices beneath the Putative Transmembrane Domain
- 1 October 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (44) , 30300-30310
Open AccessThree-dimensional Reconstruction of Human Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Revealed an Ellipsoidal Structure with Orifices beneath the Putative Transmembrane Domain